Patent ID: 8309543

Claim:
A method of inhibiting one or more of NaV1.1, NaV1.2, NaV1.3, NaV1.4, NaV1.5, NaV1.6, NaV1.7, NaV1.8, NaV1.9, or CaV2.2 activity in: (a) a patient; or (b) a biological sample; which method comprising administering to said patient, or contacting said biological sample with a compound selected from the following: # Compound 223 385 487 494 496 499 538 540 541 550 557 562 563 564 568 574 575 576 577 579 581 582 583 585 588 589 592 597 605 607 611 612 615 616 617 618 619 620 621 622 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 647 656 657 658 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 700 708 709 710 711 712 713 714 715 716 721 722 723 724 725 726 727 734 735 740 741 742 743 744 745 746 761 762 764 765 766 767 768 769 770 774